000			03852nam a22004335i 4500
001			86051
003			ES-MaUEC
005			20230207040540.0
007			cr nn 008mamaa
008			160922s2016 gw | s |||| 0|eng d
020			_a9783319339139
040			_aES-MaUEC
050		4	_aRM315 _b.T736 2016 EB
082	0	4	_a612.8
090			_aRM315 _b.T736 2016
245	1	0	_aTranslational Neuropsychopharmacology _cedited by Trevor W Robbins, Barbara J Sahakian
260			_aCham _bSpringer International Publishing _c2016
300			_a1 recurso en línea (XII, 498 p.) _b124 ilustraciones, 92 ilustraciones en color
336			_aTexto (visual) _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
490	1		_aCurrent Topics in Behavioral Neurosciences _x1866-3370 _v28
505	0		_aTranslational mouse models of autism; Advancing towards pharmacological therapeutics -- Translatable and back-translatable measurement of impulsivity and compulsivity; convergent and divergent processes -- Translational models of gambling-related decision-making -- Translational research on nicotine dependence -- The need for treatment-responsive translatable biomarkers in alcoholism research -- On the road to translation for PTSD treatment: theoretical and practical considerations of the use of human models of conditioned fear for drug development -- Translational approaches targeting reconsolidation -- Translational assessment of reward and motivational deficits in psychiatric disorders -- Affective biases in humans and animals. Robinson -- Locomotor profiling from the rodents to the clinic and back again -- Animal models of sensori-motor gating in schizophrenia: Are they still relevant? -- Attention and the cholinergic system: relevance to schizophrenia -- Attentional-set-shifting across species -- Relating Translational Neuroimaging and Amperometric Endpoints: Utility for Neuropsychiatric Drug Discovery -- Cognitive translation using the rodent touchscreen test approach -- The Paired Associates Learning (PAL) Test: 30 years of CANTAB Translational Neuroscience From Laboratory to Bedside in Dementia Research -- Translational approaches to experimental medicine.
520			_aThis book covers wide areas of animal and human psychopharmacology with clinical utility in the treatment of psychiatric and neurological (e.g Alzheimer's disease) disorders. The main theme is to develop a new paradigm for drug discovery that questions the claim that animal models or assays fail adequately to predict Phase 3 clinical trials. A new paradigm is advocated that stresses the importance of intermediate staging points between these extremes that depend on suitable translation of findings from animal studies to Phase 1 or Phase 2 studies utilising experimental medicine. .
710	2		_aSpringerLink (Online service) _0Local _9106996
942			_2lcc _cLE
988	0	0	_aEBOOK, EBSPRINGER
650		7	_aMedicina _0comprobar BNE19900959047 _2embne _9405021
650		7	_aNeurociencias _0comprobar BNE20012490612 _2embne _9158907
650		7	_aFarmacología _0comprobar BNE19900953030 _2embne _9137893
700	1		_aRobbins, Trevor W. _eeditor literario _999459 _0Local
700	1		_aSahakian, Barbara J. _eeditor literario _999460 _0Local
830		0	_aCurrent Topics in Behavioral Neurosciences _x1866-3370 _v28 _9133305
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-33913-9 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901			_ai9783319339139
907			_a.b12953295 _b10-10-17 _c21-11-16
998			_am _a_alco _a_vill _b - - _cm _dz _e- _feng _ggw _h0
945			_aRM315 .T736 2016 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11614857 _z30-06-17
999			_c86051 _d86051 _x1